Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells

KRAS mutations in NSCLC are supposed to indicate a poor prognosis and poor response to anticancer treatments but this feature lacks a mechanistic basis so far. In tumors, KRAS was found to be mutated mostly at codons 12 and 13 and a pool of mutations differing in the base alteration and the amino ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Caiola, Elisa, Salles, Daniela, Frapolli, Roberta, Lupi, Monica, Rotella, Giuseppe, Ronchi, Anna, Garassino, Marina Chiara, Mattschas, Nikola, Colavecchio, Stefano, Broggini, Massimo, Wiesmüller, Lisa, Marabese, Mirko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745782/
https://www.ncbi.nlm.nih.gov/pubmed/26353932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745782/
https://www.ncbi.nlm.nih.gov/pubmed/26353932

Ejemplares similares